Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Microbiome Transplant in Atopic Dermatitis
NCT02144142Phase 2Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Jul 2015
- Primary completion
- Jul 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of autologous CoNS-AM+ in atopic dermatitis (AD), sponsored by University of California, San Diego. Planned start Jul 2015; status: withdrawn.
02
Drugs
autologous CoNS-AM+
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02144142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144142.